Search research articles
Contact Us
Filters
Showing results (41-50 of 48) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 48 results.
Science Translational Medicine
|
November 26, 2011
Bactericidal/permeability-increasing protein (rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow aplasia and death
Eva C Guinan, Christine M Barbon, Leslie A Kalish, et al.
Experimental Hematology
|
November 9, 2020
Inhibition of TGFβ1 and TGFβ3 promotes hematopoiesis in Fanconi anemia
Alfredo Rodríguez, Chunyu Yang, Elissa Furutani, et al.
The Journal of Biological Chemistry
|
September 30, 2016
Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models
Mindy I Davis, Rajan Pragani, Jennifer T Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 15, 2019
The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition
Kalindi Parmar, Bose S Kochupurakkal, Jean-Bernard Lazaro, et al.
Cell Stem Cell
|
September 30, 2020
MYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia
Alfredo Rodríguez, Kaiyang Zhang, Anniina Färkkilä, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Brandon M Huffman, Hanrong Feng, Kalindi Parmar, et al.
The Journal of Clinical Investigation
|
July 7, 2026
PTEN deficiency confers sensitivity to ATR inhibitor-based treatment in high-grade serous ovarian cancer
Jie Hao, Bose Kochupurakkal, Timothy B Branigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2026
A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2
Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 48) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 48 results.
Science Translational Medicine
|
November 26, 2011
Bactericidal/permeability-increasing protein (rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow aplasia and death
Eva C Guinan, Christine M Barbon, Leslie A Kalish, et al.
Experimental Hematology
|
November 9, 2020
Inhibition of TGFβ1 and TGFβ3 promotes hematopoiesis in Fanconi anemia
Alfredo Rodríguez, Chunyu Yang, Elissa Furutani, et al.
The Journal of Biological Chemistry
|
September 30, 2016
Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models
Mindy I Davis, Rajan Pragani, Jennifer T Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 15, 2019
The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition
Kalindi Parmar, Bose S Kochupurakkal, Jean-Bernard Lazaro, et al.
Cell Stem Cell
|
September 30, 2020
MYC Promotes Bone Marrow Stem Cell Dysfunction in Fanconi Anemia
Alfredo Rodríguez, Kaiyang Zhang, Anniina Färkkilä, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Brandon M Huffman, Hanrong Feng, Kalindi Parmar, et al.
The Journal of Clinical Investigation
|
July 7, 2026
PTEN deficiency confers sensitivity to ATR inhibitor-based treatment in high-grade serous ovarian cancer
Jie Hao, Bose Kochupurakkal, Timothy B Branigan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2026
A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2
Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun, et al.
Page
of 5